Atlas Trials

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines

Clinical trial NCT04143854 · COMPLETED

Trial details

NCT number
NCT04143854
Sponsor
Medy-Tox
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lateral Canthal Lines
Start date
2019-05-21
Primary completion
2020-08-19
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.